The present invention relates to 2-aminoquinolines of formula I wherein R1, R2 and R3 are as defined in the specification, as 5-HT5A receptor antagonists, their manufacture, pharmaceutical compositions containing them and their use for the treatment of CNS disorders.
-
Page/Page column 14
(2009/04/24)
2-AMINOQUINOLINES
The present invention is concerned with 2-aminoquinoline derivatives of formula I wherein R1 and R2 are as described herein and pharmaceutically acceptable salts thereof, pharmaceutical compositions containing them, and methods for t
-
Page/Page column 8
(2009/09/28)
More Articles about upstream products of 1136478-92-6